申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0124091A2
公开(公告)日:1984-11-07
Glycine, sarcosine, or N,N-dimethylglycine exerts a synergistic effect upon gamma-vinyl GABA for the treatment of seizure disorders, in particular epilepsy.
甘氨酸、肌氨酸或 N,N-二甲基甘氨酸对γ-乙烯基 GABA 具有协同作用,可用于治疗癫痫发作性疾病,尤其是癫痫。